All terms in MESH
| Label | Id | Description |
|---|---|---|
| KR12 compound | C000605800 | |
| HKSOX-1 | C000605801 | |
| ethyl hydroxytyrosyl ether | C000605802 | |
| octyl hydroxytyrosyl ether | C000605803 | |
| CDb12 compound | C000605804 | |
| 68Ga-DOTA-Arg-Gly-Asp | C000605805 | |
| USP35 protein, human | C000605806 | |
| beta-lactamase OXA-48, Proteus mirabilis | C000605807 | |
| chromacef | C000605808 | |
| RmtE 16S rRNA Methyltransferase, E coli | C000605809 | |
| beta-lactamase CMY-2, E coli | C000605810 | |
| iKIX1 compound | C000605811 | |
| Growth Differentiation Factor 10 | D055413 | [A growth differentiation factor that is closely-related in structure to BONE MORPHOGENETIC PROTEIN 3. Growth differentiation factor 10 is found at high levels in BONE, however it plays an additional roles in regulating EMBRYONIC DEVELOPMENT.] |
| Cse1 protein, E coli | C000605812 | |
| Myocardial Perfusion Imaging | D055414 | [Imaging blood flow to the MYOCARDIUM by following the distribution of radioactively labeled tracers injected into the blood stream., The creation and display of functional images showing where the blood is flowing into the MYOCARDIUM by following over time the distribution of tracers injected into the blood stream.] |
| Heart Function Tests | D006334 | [Examinations used to diagnose and treat heart conditions.] |
| N,N-diethyl-5-((3-fluorophenyl)ethynyl)picolinamide | C000605813 | |
| Bone Morphogenetic Protein 4 | D055415 | [A bone morphogenetic protein that is a potent inducer of bone formation. It also functions as a regulator of MESODERM formation during EMBRYONIC DEVELOPMENT.] |
| N-(7-chloro-N-quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide | C000605814 | |
| Evidence-Based Emergency Medicine | D055416 | [A way of providing emergency medical care that is guided by a thoughtful integration of the best available scientific knowledge with clinical expertise in EMERGENCY MEDICINE. This approach allows the practitioner to critically assess research data, clinical guidelines, and other information resources in order to correctly identify the clinical problem, apply the most high-quality intervention, and re-evaluate the outcome for future improvement.] |